HSP 90α inhibitors belong to a significant class of chemical compounds that interact with and modulate the activity of the heat shock protein 90α (HSP 90α). Heat shock proteins are a crucial group of chaperone proteins that facilitate the proper folding, stabilization, and intracellular trafficking of other proteins, ensuring cellular homeostasis under normal and stress conditions. HSP 90α, a key member of the heat shock protein family, plays a pivotal role in assisting the correct folding of various client proteins, which are involved in essential cellular processes such as signal transduction, protein degradation, and cell cycle regulation.
The inhibitors targeting HSP 90α are characterized by their ability to bind to the protein's ATP-binding site, which is vital for its chaperone function. By binding to this site, HSP 90α inhibitors disrupt the protein's ATPase activity, thereby interfering with its conformational changes and leading to the destabilization of client protein complexes. This disruption has far-reaching consequences for multiple cellular pathways, affecting the stability of numerous client proteins that rely on HSP 90α for proper folding and function. Researchers have extensively studied these inhibitors to unravel the intricate mechanisms by which they interact with HSP 90α, offering insights into avenues for targeted interventions in various cellular contexts. The exploration of HSP 90α inhibitors provides valuable information about the complex network of protein interactions within cells and opens up possibilities for the development of novel strategies in diverse areas of biomedical research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90 and inhibits ATP binding, disrupting client protein folding. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Binds to Hsp90, preventing ATP binding and causing degradation of clients. | ||||||
17-DMAG | 467214-20-6 | sc-202005 | 1 mg | $205.00 | 8 | |
Binds to Hsp90, leading to client protein degradation and anti-cancer effects. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
Potent Hsp90 inhibitor, leading to proteasomal degradation of client proteins. | ||||||
BIIB 021 | 848695-25-0 | sc-364434 sc-364434A | 5 mg 25 mg | $128.00 $650.00 | ||
Inhibits Hsp90, causing degradation of client proteins and potential anti-cancer effects. | ||||||
Debio 0932 | 1061318-81-7 | sc-507516 | 10 mg | $280.00 | ||
Binds to Hsp90 and impairs its function, leading to degradation of client proteins. | ||||||
AT13387 | 912999-49-6 | sc-364415 sc-364415A | 10 mg 50 mg | $555.00 $1606.00 | ||
Binds to Hsp90, causing destabilization of client proteins and their degradation. | ||||||